Articles from Alembic Therapeutics

Alembic Therapeutics, LLC Announces Acquisition of NUVESSA® (metronidazole vaginal gel 1.3%) from Exeltis USA, Inc.
By Alembic Therapeutics · Via GlobeNewswire · June 9, 2026
Alembic Therapeutics LLC Announces the Launch of PIVYA® (pivmecillinam)
Pivya® (pivmecillinam) Tablets, 185mg
By Alembic Therapeutics · Via GlobeNewswire · February 18, 2026